QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Congress mandates phaseout of 'forever chemicals' in consumer products within 10 years

S. 4153 — Forever Chemical Regulation and Accountability Act of 2026 · Filed by Richard Durbin (D-IL) · Introduced Mar 19, 2026 · Referred to committee

75%
Transparency
Typical bill: 82%
15/100
Hidden-provision risk
Typical bill: 15/100
Environmental Health Protection & Phaseout

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill phases out nonessential uses of PFAS ('forever chemicals') in the U.S. over 10 years, with accelerated bans on specific consumer products (carpets, food packaging, cosmetics, apparel) within 1–5 years. It requires manufacturers and users to report annually on their PFAS use, submit phaseout plans, and eventually eliminate all detectable releases. The bill funds scientific review by the National Academies to identify which PFAS uses are truly essential (e.g., medical devices, aerospace) and which can be replaced. Citizens and states gain the right to sue for violations.

Why we flagged it

The bill's core mechanism is a mandatory, science-based phaseout of nonessential PFAS uses with citizen enforcement. It is not a subsidy, carve-out, or deregulation—it is a direct restriction on manufacturing and release, backed by civil and criminal penalties.

What the text implies

  • The 10-year timeline for full nonessential-use phaseout may allow continued PFAS releases during the transition period, delaying health benefits for vulnerable populations already exposed.
  • The 'essential use' designation process relies on National Academies recommendations but gives the Administrator discretion to override or delay—creating potential for regulatory capture if industry lobbies for broad 'essential' carve-outs.

The full analysis lists 5 implications of this text.

Who stands to gain

Chemical manufacturers developing PFAS alternatives and substitutes; Environmental remediation and water treatment companies; Research institutions and Centers of Excellence (funded for PFAS research)

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record